ZR2 Bioenergy Limited (BOM:506640)
India · Delayed Price · Currency is INR 121.55
+0.05 (0.04%)
At close: Jun 17, 2026
ZR2 Bioenergy Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | - | 14.95 | 15.74 | - | 11.56 |
Other Revenue | - | 0.2 | - | - | 0 |
| - | 15.15 | 15.74 | - | 11.56 | |
Revenue Growth (YoY) | - | -3.75% | - | - | - |
Cost of Revenue | 1.21 | 12.95 | 13.22 | - | 9 |
Gross Profit | -1.21 | 2.2 | 2.51 | - | 2.56 |
Selling, General & Admin | 2.03 | 1.92 | 0.17 | 0.75 | 1.25 |
Other Operating Expenses | 3.58 | 2.91 | 1.18 | 0.22 | 0.82 |
Operating Expenses | 7.73 | 5.26 | 1.37 | 0.99 | 2.1 |
Operating Income | -8.94 | -3.06 | 1.15 | -0.99 | 0.45 |
Interest Expense | -0.01 | -0 | -1.94 | -0.14 | -0 |
Interest & Investment Income | - | 4.9 | 2.39 | 1.65 | 2.75 |
Other Non Operating Income (Expenses) | 18.68 | - | - | 0.03 | -0 |
EBT Excluding Unusual Items | 9.74 | 1.84 | 1.6 | 0.55 | 3.19 |
Gain (Loss) on Sale of Investments | - | 0.18 | 0.75 | -0.23 | 0 |
Gain (Loss) on Sale of Assets | - | - | 1.46 | - | - |
Pretax Income | 9.74 | 2.02 | 3.81 | 0.33 | 3.2 |
Income Tax Expense | -0.3 | 1.12 | -0.08 | -0.03 | -0.73 |
Net Income | 10.04 | 0.9 | 3.89 | 0.36 | 3.92 |
Net Income to Common | 10.04 | 0.9 | 3.89 | 0.36 | 3.92 |
Net Income Growth | 1013.41% | -76.82% | 986.76% | -90.87% | 326.57% |
Shares Outstanding (Basic) | 4 | 4 | 3 | 2 | 2 |
Shares Outstanding (Diluted) | 16 | 42 | 3 | 2 | 2 |
Shares Change (YoY) | -61.90% | 1231.40% | 94.13% | - | - |
EPS (Basic) | 2.81 | 0.25 | 1.24 | 0.22 | 2.42 |
EPS (Diluted) | 0.63 | 0.02 | 1.24 | 0.22 | 2.42 |
EPS Growth | 3050.00% | -98.39% | 462.92% | -90.92% | 326.54% |
Free Cash Flow | -19.23 | -884.4 | -201.93 | -113.45 | 9.05 |
Free Cash Flow Per Share | -1.21 | -21.14 | -64.25 | -70.08 | 5.59 |
Dividend Per Share | - | 0.100 | - | - | - |
Gross Margin | - | 14.52% | 15.97% | - | 22.12% |
Operating Margin | - | -20.21% | 7.28% | - | 3.90% |
Profit Margin | - | 5.96% | 24.73% | - | 33.93% |
Free Cash Flow Margin | - | -5839.19% | -1283.17% | - | 78.33% |
EBITDA | -6.81 | -2.63 | 1.16 | -0.97 | 0.48 |
EBITDA Margin | - | -17.34% | 7.37% | - | 4.15% |
D&A For EBITDA | 2.12 | 0.44 | 0.01 | 0.02 | 0.03 |
EBIT | -8.94 | -3.06 | 1.15 | -0.99 | 0.45 |
EBIT Margin | - | -20.21% | 7.28% | - | 3.90% |
Effective Tax Rate | - | 55.32% | - | - | - |
Revenue as Reported | 18.68 | 21.37 | 18.88 | 2.88 | 14.3 |
Advertising Expenses | - | 0.11 | 0.04 | 0.02 | 0.04 |